TWI546379B - Microrganism for forming fermentation products through fermentation of sugars - Google Patents

Microrganism for forming fermentation products through fermentation of sugars Download PDF

Info

Publication number
TWI546379B
TWI546379B TW102147336A TW102147336A TWI546379B TW I546379 B TWI546379 B TW I546379B TW 102147336 A TW102147336 A TW 102147336A TW 102147336 A TW102147336 A TW 102147336A TW I546379 B TWI546379 B TW I546379B
Authority
TW
Taiwan
Prior art keywords
microorganism
fermentation
carbon dioxide
mutated
plastid
Prior art date
Application number
TW102147336A
Other languages
Chinese (zh)
Other versions
TW201425579A (en
Inventor
李思禹
莊宗諭
李亞翰
歐陽芳鈺
Original Assignee
國立中興大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立中興大學 filed Critical 國立中興大學
Priority to TW102147336A priority Critical patent/TWI546379B/en
Publication of TW201425579A publication Critical patent/TW201425579A/en
Application granted granted Critical
Publication of TWI546379B publication Critical patent/TWI546379B/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

用於對糖發酵形成發酵產物之微生物 Microorganism for fermenting sugar to form a fermentation product

本發明係關於一種用於發酵之微生物,特別係關於一種能將含有經突變之酵素的序列之質體轉形入微生物中,致使固定二氧化碳且發酵效率變佳之微生物。 The present invention relates to a microorganism for fermentation, and more particularly to a microorganism capable of transforming a plastid containing a sequence of a mutated enzyme into a microorganism, thereby fixing carbon dioxide and improving fermentation efficiency.

一直以來,發酵食品之製造均仰賴微生物,微生物被接入原料中,在其生長過程會產生所需酵素,將有機物分解變為人類生活上有益物質的過程稱之發酵;所以實際催化此代謝活動進行者乃微生物所產生的酵素。 All along, the production of fermented foods relies on microorganisms. Microorganisms are connected to raw materials. During the growth process, the required enzymes are produced, and the process of decomposing organic matter into beneficial substances in human life is called fermentation; therefore, this metabolic activity is actually catalyzed. The performer is an enzyme produced by microorganisms.

在微生物發酵過程中依據是否須要氧氣可分為好氣性發酵及嫌氣性發酵。如黴菌培養及乙酸發酵均屬好氣性發酵;酒精發酵及乳酸發酵為嫌氣性發酵。而根據原料型態及裝置的不同也可分為固態發酵與液態發酵,固態發酵如米飯及高梁的發酵,因原料的含水量較少,雜菌污染的承受度較高,適宜開放空間的培養,如黴菌培養;液態發酵則因含水量高,微生物生長速度快,容易污染,故常採用密閉式培養,如發酵過程需要氧氣,再通入無菌空氣。 In the process of microbial fermentation, it can be divided into aerobic fermentation and anaerobic fermentation depending on whether oxygen is required. For example, mold culture and acetic acid fermentation are aerobic fermentation; alcohol fermentation and lactic acid fermentation are anaerobic fermentation. According to different raw material types and devices, it can be divided into solid fermentation and liquid fermentation, solid fermentation such as rice and sorghum fermentation. Because of the low water content of raw materials, the tolerance of mixed bacteria is high, and it is suitable for the cultivation of open space. For example, mold culture; liquid fermentation, because of high water content, rapid growth of microorganisms, easy to contaminate, it is often used in closed culture, such as the fermentation process requires oxygen, and then into the sterile air.

近年來,為了利用微生物發酵的原理製備出人類日常生活所需的 發酵製品,漸漸有了發酵工程的產業發展。而發酵工程是用來解決按發酵工藝進行工業化生產的工程學問題的領域。發酵工程從工程學的角度把實現發酵工藝的發酵工業過程分為菌種、發酵和提煉(包括廢水處理)等三個階段,這三個階段都有各自的工程學問題,一般分別把它們稱為發酵工程的上游、中游和下游工程。發酵工程的三個階段均分別有它們各自的工藝原理和設備及過程控制原理,它們一起構成發酵工程原理。 In recent years, in order to utilize the principle of microbial fermentation, it is necessary to prepare human daily life. Fermented products have gradually developed the industry of fermentation engineering. Fermentation engineering is an area that solves the engineering problems of industrial production by fermentation process. Fermentation engineering divides the fermentation industrial process that realizes the fermentation process into three stages: strain, fermentation and refining (including wastewater treatment) from the engineering point of view. These three stages have their own engineering problems, which are generally called respectively. It is the upstream, midstream and downstream projects of the fermentation project. The three stages of the fermentation project have their respective process principles and equipment and process control principles, which together constitute the principle of fermentation engineering.

其中,發酵工程牽涉到碳的化學,而碳在發酵工程代謝過程中,最後以二氧化碳之型態進入生態圈。而二磷酸核酮糖羧化酶/加氧酶(ribulose bisphosphate carboxylase/oxygenase;RubisCO)即為自然界中扮演著將二氧化碳轉化成生物質(biomass)之酵素。此為普遍常見之酵素;但是,二磷酸核酮糖羧化酶/加氧酶是目前生物工程中進行代謝速率較緩慢之酵素(Kcat~3/s),目前尚不清楚為何其速率如此緩慢且專一性低,而許多所 Among them, the fermentation engineering involves the chemistry of carbon, and the carbon enters the ecological circle in the form of carbon dioxide in the metabolic process of fermentation engineering. The ribulose bisphosphate carboxylase/oxygenase (RubisCO) is an enzyme that plays a role in converting carbon dioxide into biomass (biomass) in nature. This is a common enzyme; however, ribulose bisphosphate carboxylase/oxygenase is currently a slower metabolic enzyme (Kcat~3/s) in bioengineering. It is not clear why its rate is so slow. And low specificity, and many

然而,此發酵過程中,利用微生物生產小分子化學品如生質乙醇或生質丁醇等皆是專注在如何有效地產生,尚未考慮到小分子化學品做出後,一旦開始量產,伴隨而來的就是大量二氧化碳的排放,例如生產一莫耳的乙醇即會產生一莫耳的二氧化碳,鮮少有人專注於二氧化碳的固定或回收以及其更進一步之利用。僅在美國專利US 20080085341中,其提供一種利用具有至少一種外源基因(heterologous gene)序列來形成發酵產物,該外源基因序列所表現之外源蛋白能使外來碳源轉化成及將二氧化碳固定化為所欲之發酵產物;其雖已提到固定化二氧化碳使得環境中之二氧化 碳的量不再增加,但其並未更進一步地提升發酵效率、產能以及生物工程等工業應用程序。 However, in this fermentation process, the use of microorganisms to produce small molecule chemicals such as bioethanol or bio-butanol is focused on how to effectively produce it, and after taking into account the production of small molecule chemicals, once mass production is started, The result is a large amount of carbon dioxide emissions, such as the production of a molar ethanol will produce a mole of carbon dioxide, few people focus on the fixation or recycling of carbon dioxide and its further use. Only in U.S. Patent No. 20080085341, which provides a method for forming a fermentation product using at least one heterologous gene sequence which exhibits an exogenous protein capable of converting a foreign carbon source into and fixing carbon dioxide. To the desired fermentation product; although it has been mentioned that immobilized carbon dioxide makes the environment oxidize The amount of carbon is no longer increasing, but it does not further improve industrial applications such as fermentation efficiency, capacity, and bioengineering.

有鑒於此,本發明之目的係提供一種微生物,該微生物可專注於發酵工程之過程中二氧化碳之固定與回收,使得在發酵工業中的二氧化碳排放量減少,減輕地球上二氧化碳過多之負擔。 In view of the above, it is an object of the present invention to provide a microorganism which can focus on the fixation and recovery of carbon dioxide during the fermentation process, thereby reducing the amount of carbon dioxide emissions in the fermentation industry and reducing the burden of excessive carbon dioxide on the earth.

同時,本發明之另一目的是將含有突變酵素的序列之質體轉形入微生物中,使其在固定二氧化碳的前提之下提升發酵的效率。 At the same time, another object of the present invention is to transform a plastid containing a sequence of a mutant enzyme into a microorganism to enhance the efficiency of fermentation under the premise of fixing carbon dioxide.

為達上述目的,本發明提供一種用於對受質發酵形成發酵產物之微生物,其包含含有經突變之酵素序列之質體或染色體,經突變或非經突變之酵素係包含選自由以下序列結構之質體或染色體所構成之群組:pACYC184-PrkA/pET-rbcLSm1/tktA(JB/PTA)及pACYC184-PrkA/pET-rbcLSm1/talB(JB/pTB);其中,受質為六碳糖、六碳糖衍生物或其組合;其中,具備該序列結構之質體或染色體之微生物發酵後每單位C2有機物消耗量之二氧化碳排放量增加較野生型菌株減少6.25%-15.6%。 In order to achieve the above object, the present invention provides a microorganism for forming a fermentation product by fermentation, which comprises a plastid or a chromosome containing a mutated enzyme sequence, and the mutated or non-mutated enzyme comprises a structure selected from the following sequence a group of plastids or chromosomes: pACYC184-PrkA/pET-rbcLSm1/tktA (JB/PTA) and pACYC184-PrkA/pET-rbcLSm1/talB (JB/pTB); wherein the receptor is a six-carbon sugar, A hexasaccharide derivative or a combination thereof; wherein the carbon dioxide emission per unit C2 organic matter consumption after fermentation of the plastid or chromosome having the sequence structure is reduced by 6.25%-15.6% compared with the wild type strain.

於本發明之一較佳實施例,微生物可為真菌。 In a preferred embodiment of the invention, the microorganism can be a fungus.

較佳地,真菌可為酵母菌屬。 Preferably, the fungus can be a genus of yeast.

於本發明之另一較佳實施例,微生物可為細菌或古細菌(archaea)或其組合。 In another preferred embodiment of the invention, the microorganism can be a bacterium or an archaea or a combination thereof.

較佳地,細菌可為大腸桿菌(Escherichia coli)、丙酮丁醇梭桿菌(Clostridium acetobutylicum)、枯草芽孢桿菌(Bacillus subtilis)、戀臭假單胞菌(Pseudomonas putia)、藍藻細菌(cyanobacteria)、貪銅菌屬(Cupriavidus spp.)、或運動發酵單胞菌(Zymomonas mobilis)或其組合。 Preferably, the bacteria may be Escherichia coli, Clostridium acetobutylicum, Bacillus subtilis (Bacillus). Subtilis), Pseudomonas putia, cyanobacteria, Cupriavidus spp., or Zymomonas mobilis, or a combination thereof.

於本發明之另一較佳實施例,微生物可為藻類。 In another preferred embodiment of the invention, the microorganism can be an alga.

較佳地,六碳糖衍生物為六碳糖所聚合之雙糖、寡聚醣或多醣。 Preferably, the hexasaccharide derivative is a disaccharide, oligosaccharide or polysaccharide polymerized by a hexose.

本發明的許多特徵及優點將參照後文與附圖相關之詳細說明而變得更容易理解。 Many of the features and advantages of the present invention will become more apparent from the detailed description of the appended claims.

第一圖為各種菌株僅在LB培養基好氧情況下的生長曲線。 The first plot shows the growth curves of various strains only under aerobic conditions in LB medium.

第二圖為各種菌株在含有阿拉伯糖之LB培養基好氧情況下(A)生長曲線及(B)糖含量。 The second graph shows the (A) growth curve and (B) sugar content of various strains in aerobic conditions of LB medium containing arabinose.

第三圖為各株大腸桿菌發酵後所產生的二氧化碳與乙酸、二氧化碳與乙醇的比例示意圖。 The third figure is a schematic diagram showing the ratio of carbon dioxide produced by fermentation of Escherichia coli to acetic acid, carbon dioxide and ethanol.

第四圖為發酵槽各菌株中每單位糖消耗量之二氧化碳排放量之柱狀比較圖。 The fourth graph is a bar graph comparing the carbon dioxide emissions per unit of sugar consumption in each strain of the fermentation tank.

第五圖為發酵槽各菌株中每單位糖消耗量之乙醇及乙酸之產量之柱狀比較圖。 The fifth graph is a bar graph comparing the yield of ethanol and acetic acid per unit sugar consumption in each strain of the fermentation tank.

第六圖為發酵槽各菌株中每單位乙醇及醋酸產量之二氧化碳排放量之柱狀比較圖。 The sixth graph is a bar graph comparing the CO2 emissions per unit of ethanol and acetic acid production in each strain of the fermentation tank.

後文所提供與附圖相關之詳細說明係意欲為本發明實施例之敘述,但並非意欲代表本發明實施例可被建構或利用的唯一型式。實 施例所提到的功能及步驟之順序係用以建構及操作實施例。然而,相同或均等的功能或順序可由不同之實施例所達成。 The detailed description of the present invention is intended to be illustrative of the embodiments of the invention, and is not intended to represent the invention. real The order of the functions and steps mentioned in the examples is used to construct and operate the embodiments. However, the same or equivalent functions or sequences may be achieved by different embodiments.

為了方便,於說明書、實施例及後附之申請專利範圍所採用之實施例係在此集中。除非另外定義,所有於本文中所使用的技術及科學的專有名詞對於所屬領域具備通常知識者而言具有一般所能理解的相同意義。 For the sake of convenience, the embodiments employed in the specification, examples, and appended claims are hereby incorporated by reference. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.

除非本文另外清楚地指出,單數形式”一”、”及”與”該”用於本文中係可包含單數或複數個指涉物。 The singular forms "a", "the", and "the"

術語「固定」係作用於本文中的二氧化碳,係代表將二氧化碳轉化及/或將二氧化碳的碳原子併入有機分子中,使得在發酵工程中所產出的二氧化碳可無限的循環。 The term "fixed" as used herein refers to the conversion of carbon dioxide and/or the incorporation of carbon atoms of carbon dioxide into organic molecules such that the carbon dioxide produced in the fermentation process can be recycled indefinitely.

術語「微生物」於本文中之定義為可對受質發酵形成發酵產物之生物體,並不受限於傳統習知之微生物。 The term "microorganism" is defined herein as an organism that can form a fermentation product for fermentation by fermentation, and is not limited to conventional microorganisms.

本發明係提供一種用於對受質發酵形成發酵產物之微生物,其包含含有經突變或非經突變之酵素序列之質體或染色體,此序列可為核苷酸序列或蛋白質序列,經突變或非經突變之酵素係選自由以下的EC編號(Enzyme Commission number)所構成之群組:2.7.1、5.1.3、5.3.1、4.1.1、2.2.1、及3.1.3;其中,受質為六碳糖、六碳糖衍生物或其組合。 The present invention provides a microorganism for forming a fermentation product by fermentation, which comprises a plastid or a chromosome containing a mutated or non-mutated enzyme sequence, which may be a nucleotide sequence or a protein sequence, which is mutated or The non-mutated enzyme is selected from the group consisting of the following EC number (Enzyme Commission number): 2.7.1, 5.1.3, 5.3.1, 4.1.1, 2.2.1, and 3.1.3; The receptor is a six carbon sugar, a six carbon sugar derivative or a combination thereof.

其中,EC編號2.7.1較佳為磷酸核酮糖激酶(phosphoribulokinase,EC編號:2.7.1.19);EC編號5.1.3較佳為磷酸核酮糖表異構酶(Ribulose-phosphate 3-epimerase,EC編號:5.1.3.1)、5-磷酸L型核酮糖4-表異構酶 (L-ribulose-5-phosphate 4-epimerase,EC編號:5.1.3.4)、5-磷酸L型核酮糖3-表異構酶(L-ribulose-5-phosphate 3-epimerase,EC編號:5.1.3.22);EC編號5.3.1較佳為5-磷酸核糖異構酶/磷酸戊糖表異構酶(ribose 5-phosphate isomerase/phosphopentose epimerase,EC編號:5.3.1.6);EC編號4.1.1較佳為二磷酸核酮糖羧化酶/加氧酶(ribulose-1,5-bisphosphate carboxylase/oxygenase(RubisCo),EC編號:4.1.1.39);EC編號2.2.1較佳為轉醛醇酶(transaldolase,EC編號:2.2.1.2)、乙偶姻-5-磷酸核酮糖轉醛醇酶(acetoin-ribose-5-phosphate transaldolase,EC編號:2.2.1.4)、氟羥丁胺酸轉醛醇酶(fluorothreonine transaldolase,EC編號:2.2.1.8)、轉酮醇酶(transketolase ,EC編號:2.2.1.1)、甲醛轉酮醇酶(formaldehyde transketolase,EC編號:2.2.1.3);EC編號3.1.3較佳為景天庚酮糖-1,7-二磷酸酶(sedoheptulose 1,7-bisphosphatase,EC編號:3.1.3.37)。 Among them, EC number 2.7.1 is preferably phosphoribulokinase (EC number: 2.7.1.19); EC number 5.1.3 is preferably ribulose-phosphate 3-epimerase (Ribulose-phosphate 3-epimerase, EC number: 5.1.3.1), 5-phosphate ribulose 4-isomerase (L-ribulose-5-phosphate 4-epimerase, EC number: 5.1.3.4), L-ribulose-5-phosphate 3-epimerase, EC number: 5.1 .3.22); EC number 5.3.1 is preferably ribose 5-phosphate isomerase/phosphopentose epimerase (EC number: 5.3.1.6); EC number 4.1.1 Preferably, ribulose-1, 5-bisphosphate carboxylase/oxygenase (RubisCo), EC number: 4.1.1.39); EC number 2.2.1 is preferably transaldolase (transaldolase, EC number: 2.2.1.2), acetoin-ribose-5-phosphate transaldolase (EC number: 2.2.1.4), fluorohydroxybutyrate transaldehyde Alcoholase (EC number: 2.2.1.8), transketolase (EC number: 2.2.1.1), formaldehyde transketolase (EC number: 2.2.1.3); EC number 3.1. 3 is preferably sedoheptulose 1,7-bisphosphatase (EC number: 3.1.3.37).

其中,發酵產物可為氫氣、核苷酸、胺基酸、醇類如乙醇、丁醇、異丁醇、丙二醇異構物、山梨糖醇(sorbitol)、烯類如乙烯、丙烯、異戊二烯(isoprene)、有機酸如脂肪酸、琥珀酸、莽草酸、乙酸、酯類如生質柴油(biodiesel)、聚(3-羥丁酸酯)(poly(3-hydroxybutyrate),PHB)、烷烯烴類碳氫化合物(hydrocarbons)、有機酸如琥珀酸(succinic acid)、衣康酸(itaconic acid)、乙醯丙酸(levulinic acid)、3-羥基丙酸(3-hydroxypropiohic acid)、聚乳酸纖維(polylactic acid)及生物質(biomass)等。 The fermentation product may be hydrogen, nucleotides, amino acids, alcohols such as ethanol, butanol, isobutanol, propylene glycol isomers, sorbitol, alkenes such as ethylene, propylene, isoprene. Isoprene, organic acids such as fatty acids, succinic acid, shikimic acid, acetic acid, esters such as biodiesel, poly(3-hydroxybutyrate, PHB), alkene Hydrocarbons, organic acids such as succinic acid, itaconic acid, levulinic acid, 3-hydroxypropiohic acid, polylactic acid fiber (polylactic Acid) and biomass (biomass).

其中,聚(3-羥丁酸酯)為生物可降解性材料 Among them, poly(3-hydroxybutyrate) is a biodegradable material

其中,本發明之微生物可用於固定二氧化碳。 Among them, the microorganism of the present invention can be used for fixing carbon dioxide.

於本發明之一較佳實施例,微生物可為真菌(Fungi)。 In a preferred embodiment of the invention, the microorganism can be a fungus (Fungi).

其中,上述之真菌可為酵母菌屬(Saccharomycesspp.)。 Among them, the above fungus may be a genus of the genus Saccharomycesspp.

於本發明之另一較佳實施例,微生物可為細菌。 In another preferred embodiment of the invention, the microorganism can be a bacterium.

其中,上述之細菌可為大腸桿菌(Escherichia coli.)、丙酮丁醇梭桿菌(Clostridium acetobutylicum)、枯草芽孢桿菌(Bacillus subtilis)、戀臭假單胞菌(Pseudomonas putia)、藍藻細菌(cyanobacteria)、貪銅菌屬(Cupriavidus spp.)或運動發酵單胞菌(Zymomonas mobilis)或其組合。 Among them, the above bacteria may be Escherichia coli., Clostridium acetobutylicum, Bacillus subtilis, Pseudomonas putia, cyanobacteria, Chromium (Cupriavidus spp.) or Zymomonas mobilis or a combination thereof.

於本發明之另一較佳實施例,微生物可為藻類(algae)。 In another preferred embodiment of the invention, the microorganism can be an algae.

其中,六碳糖之衍生物可為六碳糖聚合之雙糖、寡聚醣或多醣。應注意的是,雙糖、寡聚醣或多醣係包含,但不限於所屬領域通常知識者所認知的六碳糖所聚合之雙糖、寡聚醣或多醣。 Among them, the derivative of the hexasaccharide may be a disaccharide, oligosaccharide or polysaccharide polymerized by a hexose. It should be noted that the disaccharide, oligosaccharide or polysaccharide comprises, but is not limited to, disaccharides, oligosaccharides or polysaccharides polymerized by hexoses known to those of ordinary skill in the art.

此外,本發明可藉由不斷地固定發酵後所產生之二氧化碳,藉由此手段使得發酵產物之氣體僅剩下氫氣,因此本發明亦可提升氫氣除化之效率,降低氫氣純化之成本。 In addition, the present invention can continuously fix the carbon dioxide generated after the fermentation, and the gas of the fermentation product only leaves hydrogen gas. Therefore, the present invention can also improve the efficiency of hydrogen removal and reduce the cost of hydrogen purification.

後述的實例係提供以闡述本發明的某些態樣且輔助所屬領域通常知識者實踐本發明。這些實例並非被視為限制本發明之範圍的手段。 The examples described below are provided to illustrate certain aspects of the invention and to assist those skilled in the art to practice the invention. These examples are not to be construed as limiting the scope of the invention.

實例 Instance

本發明將參照後文中的數個實施例做更進一步地描述經修飾之微生物於發酵之性質及應用,其僅作為例示性之說明,而非意欲限制本發明之申請專利範圍。 The present invention will further describe the nature and application of the modified microorganisms in the fermentation with reference to the following examples, which are intended to be illustrative only and not intended to limit the scope of the invention.

實例 Instance

本發明將參照後文中的數個實施例做更進一步地描述經修飾之微生物於發酵之性質及應用,其僅作為例示性之說明,而非意欲限制本發明之申請專利範圍。 The present invention will further describe the nature and application of the modified microorganisms in the fermentation with reference to the following examples, which are intended to be illustrative only and not intended to limit the scope of the invention.

實例1 Example 1

本實驗中發酵過程所使用之菌種為E.coli BL21(DE3)(以下簡稱大腸桿菌),而欲轉殖入大腸桿菌之酵素為經突變的二磷酸核酮糖羧化酶/加氧酶(RbcLS)及磷酸核酮糖激酶(PrkA)。此二酵素之等位基因突變序列則參照Parikh等人之學術論文(Parikh et.al.,Directed evolution of RuBisCO hypermorphs through genetic selection in engineered E.coli,2006,Protein Engineering,Design & Selection,19:113.)中的方法處理,突變的序列本身、其N端編碼、限制酶等切割及次選殖(subclone)方式以及與本發明之菌株的處理方式與此論文相同,此為所屬領域通常知識者所習知之技術,在此不再贅述。經過各個步驟的處理之後,經處理之質體最終之結構為pACYC184-PrkA、pET-rbcLS、pET-rbcLSm1,並將其分別轉形至大腸桿菌且分別命名為J1、J2及J3。此外,另外將pACYC184-PrkA及pET-rbcLS共同轉形至大腸桿菌,將其稱為JA;亦將pACYC184-PrkA及pET -rbcLSm1共同轉形至大腸桿菌,將其稱為JB。此外,雖然本實施例是將所需序列之條件插入質體中,但其僅為例示性,不為限制性,例如,本發明亦可將所欲序列之條件插入染色體中,且插入染色體的優點是使得本發明之生物工程系統呈現更加穩定的狀態。再者,本實施例係利用T7啟動子系統進行試驗,但其不為限制性,任何習知的啟動子系統皆可應用於本發明中。應注意的是,本實施例僅利用上述之突變的酵素作為實驗性的說明,其他相關的經突變處理之酵素,例如:二磷酸核酮糖羧化酶活化酶、磷酸核酮糖激酶、1,5-二磷酸核酮糖表異構酶、二磷酸核酮糖羧化酶/加氧酶第I型、二磷酸核酮糖羧化酶/加氧酶第II型、二磷酸核酮糖羧化酶/加氧酶第III型、二磷酸核酮糖羧化酶/加氧酶第IV型,或者是可代謝糖類相關物質的酵素,例如:磷酸戊糖表異構酶、5-磷酸核糖異構酶、轉醛醇酶、轉酮醇酶及景天庚酮糖-1,7-二磷酸酶等,皆可應用於本實驗中。 The strain used in the fermentation process in this experiment is E.coli BL21(DE3) (hereinafter referred to as Escherichia coli), and the enzyme to be transferred into Escherichia coli is the mutated ribulose bisphosphate carboxylase/oxygenase. (RbcLS) and ribulose phosphate kinase (PrkA). The allele mutation sequence of the two enzymes is described in Parikh et. al., Directed evolution of RuBisCO hypermorphs through genetic selection in engineered E.coli, 2006, Protein Engineering, Design & Selection, 19:113. In the method of treatment, the mutated sequence itself, its N-terminal coding, restriction enzymes and the like, and the subclone method, and the treatment method of the strain of the present invention are the same as the paper, which is a common knowledge in the field. The known techniques are not described here. After treatment with each step, the final structure of the treated plasmid was pACYC184-PrkA, pET-rbcLS, pET-rbcLSm1, and transformed into E. coli and named J1, J2 and J3, respectively. In addition, pACYC184-PrkA and pET-rbcLS were additionally transformed into Escherichia coli, which is called JA; pACYC184-PrkA and pET were also added. -rbcLSm1 is co-transformed into E. coli and is referred to as JB. In addition, although the present embodiment inserts the condition of the desired sequence into the plastid, it is merely exemplary and not limiting. For example, the present invention can also insert the condition of the desired sequence into the chromosome and insert the chromosome. The advantage is that the bioengineering system of the invention presents a more stable state. Furthermore, this embodiment uses the T7 startup subsystem for testing, but it is not limiting, and any conventional startup subsystem can be applied to the present invention. It should be noted that this example only uses the above-mentioned mutant enzyme as an experimental description, and other related mutant-treated enzymes, such as: ribulose bisphosphate carboxylase activating enzyme, phosphoribril kinase, 1 , 5-ribulose ribulose epimerase, ribulose bisphosphate carboxylase/oxygenase type I, ribulose bisphosphate carboxylase/oxygenase type II, ribulose diphosphate Carboxylase/oxygenase type III, ribulose bisphosphate carboxylase/oxygenase type IV, or an enzyme that metabolizes sugar-related substances, such as: pentose phosphate isomerase, 5-phosphate Ribosomerase, transaldolase, transketolase and sedoheptulose-1,7-bisphosphatase can be used in this experiment.

實例2 Example 2

將菌種活化時使用的培養基為無菌蛋白腖培養基(Luria Broth Medium)(以下簡稱為LB培養基)來培養菌種,其成分為NaCl 10g/L;胰蛋白腖(Tryptone)10g/L;及酵母萃取物(Yeast Extract)5g/L。其中,野生型之大腸桿菌不加入抗生素,係用來做為控制組;而J1中施加之抗生素為氯黴素(Chloramphenicol)34μg;J2及J3皆施加康黴素(Kanamycin)50μg;最後JA及JB則是皆分別施加氯黴素34μg及康黴素50μg。於培養過程中依據對照組或實驗組之需求選擇性地加入異丙基-β-D-硫代半乳糖苷(IPTG)。 The culture medium used for the activation of the strain is a sterile protein medium (Luria Broth Medium) (hereinafter referred to as LB medium), and the composition thereof is NaCl 10 g/L; tryptone 10 g/L; and yeast extract. (Yeast Extract) 5g/L. Wherein the wild-type E. coli by adding antibiotics, as a system for controlling group; and applying the antibiotic chloramphenicol as J1 (Chloramphenicol) 34 μ g; J2 and J3 are Shijia Kang neomycin (Kanamycin) 50 μ g ; Finally, JA and JB are respectively applied to both chloramphenicol and 34 μ g amphotericin Kang 50 μ g. Isopropyl-β-D-thiogalactoside (IPTG) was selectively added during the cultivation according to the needs of the control group or the experimental group.

之後,進行批次培養程序,將大腸桿菌以125mL無菌有溝錐形瓶培養,錐形瓶內含有25mL之LB培養基,培養環境為好氧環境下以37℃、200r.p.m.活化12小時(preculture)以提高菌體活性,並在適當時間進行取樣。 After that, the batch culture procedure was carried out, and Escherichia coli was cultured in a 125 mL sterile grooved conical flask. The Erlenmeyer flask contained 25 mL of LB medium, and the culture environment was activated in an aerobic environment at 37 ° C, 200 r. pm for 12 hours (preculture) ) to increase the activity of the cells and to take samples at appropriate times.

接著,發酵槽則以3L槽體進行半厭氧式發酵,槽體內有1L LB培養基;培養環境為37℃、150r.p.m.,並連續觀測LB培養基中二氧化碳之溶解量,然後在間隔時間取點,進行代謝物分析與LB培養基中的醣含量。 Next, the fermentation tank is subjected to semi-anaerobic fermentation in a 3L tank, and 1L LB medium is in the tank; the culture environment is 37 ° C, 150 r. pm, and the amount of carbon dioxide dissolved in the LB medium is continuously observed, and then taken at intervals. , metabolite analysis and sugar content in LB medium.

其中,所使用之LB培養基含有20g/L的阿拉伯糖(L-Arabinose)以及相對應之抗生素;然而,阿拉伯糖於本實施例中僅為例示性,非為限制性,其他的五碳糖,例如:木糖或與其他五碳糖之組合,以及六碳糖,例如:葡萄糖、半乳糖、果糖、甘露糖或其組合皆可輕易地利用於本實驗中。 Wherein, the LB medium used contains 20 g/L of arabinose (L-Arabinose) and the corresponding antibiotic; however, the arabinose is merely exemplary in the embodiment, not limiting, and other five carbon sugars, For example, xylose or a combination with other five carbon sugars, as well as six carbon sugars such as glucose, galactose, fructose, mannose or combinations thereof, can be readily utilized in this experiment.

實例3 Example 3

上述活化步驟結束後以分光光度計來測定大腸桿菌細胞密度,由OD600之值來決定主要培養時之殖菌量,此步驟主要是利用大腸桿菌的吸光來測量大腸桿菌培養液的濃度,從而估計大腸桿菌的生長情況,所以通常用來指菌體細胞密度。測量之前先暖機10分鐘,再將波長調至600nm測各個樣品之吸收值;其中一開始會放入空白樣品,進行調零操作,若吸收值大於0.8則稀釋至適當倍率,再測其吸收值;培養開始之時,各菌體之起始OD600值約為0.050。 After the activation step is completed, the cell density of Escherichia coli is measured by a spectrophotometer, and the amount of bacteria in the main culture is determined by the value of OD 600. This step mainly uses the absorbance of Escherichia coli to measure the concentration of the E. coli culture solution, thereby The growth of E. coli is estimated, so it is usually used to refer to the cell density of the cells. Before the measurement, warm up for 10 minutes, then adjust the wavelength to 600nm to measure the absorption value of each sample; firstly, put the blank sample into the zero adjustment operation, if the absorption value is greater than 0.8, dilute to the appropriate magnification, and then measure the absorption. Value; at the beginning of the culture, the initial OD 600 value of each of the cells was about 0.050.

實例4 Example 4

發酵時進行阿拉伯糖之定量測試,以比較其發酵效率。先取1m樣品以13,300rpm離心10分鐘,接著取出上清液,並稀釋至適當倍率後,以1:1的比例加入DNS試劑(10g/L的二硝基水楊酸(dinitrosalicylic acid)、16g/L的氫氧化鈉及300g/L的酒石酸鉀鈉(potassium sodium tartrate))。接著以100℃水浴避光加熱10分鐘後,再避光冷卻5分鐘。最後以分光光度計測其波長在550nm之吸收值,若吸收值大於0.8,則稀釋至適當倍率,再測其吸收值。 A quantitative test of arabinose was carried out during fermentation to compare the fermentation efficiency. First, take a 1m sample and centrifuge at 13,300rpm for 10 minutes. Then remove the supernatant and dilute to the appropriate ratio. Add DNS reagent (10g/L dinitrosalicylic acid, 16g/) in a ratio of 1:1. L sodium hydroxide and 300 g/L potassium sodium tartrate). Then, the mixture was heated in a water bath at 100 ° C for 10 minutes in the dark, and then cooled in the dark for 5 minutes. Finally, the absorption value of the wavelength at 550 nm is measured by a spectrophotometer. If the absorption value is greater than 0.8, the dilution is performed to an appropriate magnification, and the absorption value is measured.

由之前所做的檢量線即可得知發酵液中還原糖之含量。 The content of reducing sugar in the fermentation broth can be known from the previous calibration curve.

實例5 Example 5

接下來,另外再將大腸桿菌分別置入經突變的二磷酸核酮糖羧化酶/加氧酶(RbcLS mutant A)、磷酸核酮糖激酶(PrkA)另再放置轉醛醇酶(transaldolase B)或轉酮醇酶(transketolase A)基因片段。由於轉醛醇酶與轉酮醇酶為非氧化性五碳糖磷酸途徑(non-oxidative pentose phosphate pathway)最主要之酵素,該途徑是將六碳糖轉化成五碳糖供給代謝作用使用,其中轉醛醇酶與轉酮醇酶分別扮演了轉換兩個碳與三個碳的角色。 Next, E. coli was separately placed into the mutated ribulose ribose carboxylase/oxygenase (RbcLS mutant A), ribulose kinase (PrkA), and transaldolase B (transaldolase B). Or a transketolase A gene fragment. Since transaldolase and transketolase are the most important enzymes in the non-oxidative pentose phosphate pathway, this pathway is used to convert six-carbon sugar into five-carbon sugar for metabolism. Transaldolase and transketolase play the role of converting two carbons and three carbons, respectively.

首先,先取出些許菌液至比色槽中,並放至UV/Vis中,設定波長為600nm並測定其吸光值,即為菌體濃度。 First, first remove some bacteria liquid into the colorimetric cell, and put it into UV/Vis, set the wavelength to 600nm and measure its absorbance, which is the cell concentration.

接著,進行還原醣之測定。首先,以吸收值v.s.濃度作圖製備檢量線之方式與實例4相似,在此不再贅述。 Next, the measurement of the reducing sugar was carried out. First, the method of preparing the calibration curve by the absorption value v.s. concentration is similar to that of the example 4, and details are not described herein again.

製備檢量線後,取1ml的樣品與+1ml DNS試劑混合(1:1)。再取1ml去離子水與1ml DNS試劑做為空白試驗組(Blank)。然後 100℃水浴加熱10分鐘,且避光冷卻5分鐘。接著將分光光度計波長設定至550nm後,將空白試驗組歸零。測樣品之吸收值並記錄。將測得吸收值帶入先前製備檢量線回推即可得知還原醣濃度。 After preparing the calibration curve, 1 ml of the sample was mixed with +1 ml of DNS reagent (1:1). Take 1 ml of deionized water and 1 ml of DNS reagent as a blank test group (Blank). then Heat in a 100 ° C water bath for 10 minutes and cool in the dark for 5 minutes. Next, after setting the wavelength of the spectrophotometer to 550 nm, the blank test group was reset to zero. The absorbance of the sample was measured and recorded. The concentration of the reducing sugar can be known by taking the measured absorption value into the previously prepared calibration line.

發酵過程中,菌體所代謝之產物(乙醇、乙酸)係以氣相層析儀進行定量分析。其步驟為,將發酵液以13300r.p.m,離心5分鐘,取其上清液,以0.2μm針頭式過濾器過濾,再透過自動注射器(Hewlett Packard 7673)注入樣品於氣相層析儀(Hewlett Packard HP 5890 Series II)來量測其發酵產物的濃度。氣相層析儀中毛細管柱為DP-FFAP(30m×0.32mm×0.25μm),起始溫度為50℃,維持4分鐘,後以20℃/min升溫至100℃,維持1分鐘,最後再以30℃/min升溫至170℃,維持2.5分鐘;注射孔(injector)和火焰離子偵測器(FID)溫度均為225℃,分流比為10;載送氣體(carrier gas)為氮氣;注射樣品量為1μL。 During the fermentation process, the products (ethanol, acetic acid) metabolized by the cells were quantitatively analyzed by gas chromatography. The procedure is as follows: the fermentation broth is centrifuged at 13300 rpm for 5 minutes, the supernatant is taken, filtered through a 0.2 μm needle filter, and the sample is injected into the gas chromatograph through a auto-injector (Hewlett Packard 7673) (Hewlett) Packard HP 5890 Series II) was used to measure the concentration of the fermentation product. The capillary column in the gas chromatograph is DP-FFAP (30m×0.32mm×0.25 μm ), the initial temperature is 50°C, and the temperature is maintained for 4 minutes, then the temperature is raised to 100°C at 20°C/min for 1 minute. Then, the temperature was raised to 170 ° C at 30 ° C / min for 2.5 minutes; the injection hole and flame ion detector (FID) temperature were both 225 ° C, the split ratio was 10; the carrier gas was nitrogen; The amount of the injected sample was 1 μL.

其中,有關二氧化碳之測定,將待測氣體利用針筒將其從發酵的厭氧瓶中吸出,並打入1.8ml的GC樣品瓶中以作為濃縮,接著利用GC氣相針將樣品從GC瓶取出1ml,並打入二氧化碳感測器(SENTRY ST303)中測定。 Among them, regarding the determination of carbon dioxide, the gas to be tested is sucked out from the fermented anaerobic bottle by a syringe, and is put into a 1.8 ml GC sample bottle for concentration, and then the sample is taken from the GC bottle by the GC gas phase needle. 1 ml was taken out and measured in a carbon dioxide sensor (SENTRY ST303).

此外,有關pH測定,先將pH meter進行校正,校正完畢後,取出些許菌液至微量離心管中,並將pH meter至入菌液中測其pH值。 In addition, regarding the pH measurement, the pH meter is first calibrated. After the calibration is completed, a small amount of the bacterial liquid is taken out to the microcentrifuge tube, and the pH is measured in the pH liquid.

實例6 Example 6

有關轉酮醇酶與轉醛醇酶之重組質體構築,轉酮醇酶之重組質體構築(pTA)之載體為pCDFDuet-1,利用PCR技術,放大E.coli BL21(DE 3)染色體上的轉酮醇酶(TktA)的基因片段,再cloning至pCDFDuet-1質體上,即構成重組質體pTA;而轉醛醇酶(TalB)亦以相同方法進行重組質體構築(pTB)。 For recombinant plastid construction of transketolase and transaldolase, the recombinant plastid construct (pTA) of transketolase is pCDFDuet-1, which is amplified by PCR. The gene fragment of transketolase (TktA) on the chromosome of BL21(DE 3) was cloned to pCDFDuet-1 plastid to form recombinant plastid pTA; and transaldolase (TalB) was recombined in the same manner. Plastid construction (pTB).

在實驗中,為了讓擁有3個質體的JB/pTA、JB/pTB能加以表現,因此會在培養第2小時選擇性地加入IPTG(0.5mM),誘發T7啟動子,使蛋白質的量更多。培養時,以LB為培養基,葡糖糖為碳源,100mM的mops為pH緩衝液,以完全厭氧方式進行培養,培養條件為37℃,轉速為200rpm之條件進行實驗。表一則為實驗中使用的菌種與質體。 In the experiment, in order to allow JB/pTA and JB/pTB with three plastids to be expressed, IPTG (0.5 mM) was selectively added at the second hour of culture to induce a T7 promoter, and the amount of protein was increased. many. During the culture, the experiment was carried out under the conditions of LB as a medium, glucose sugar as a carbon source, 100 mM mops as a pH buffer, and complete anaerobic culture under the conditions of 37 ° C and a rotation speed of 200 rpm. Table 1 shows the strains and plastids used in the experiment.

表一、實驗中使用之菌種與質體 Table 1. Species and plastids used in the experiment

結果與討論 Results and discussion

請參見第一圖,第一圖為各種菌株僅在LB培養基好氧情況下的生長曲線。由第一圖可知,在一開始的10小時內各菌株之OD600值差 異不大,而時間至30小時之後,雙質體之大腸桿菌(JA、JB)在OD600值表現上較野生型(W.T.)之大腸桿菌低17.1%。相對地,請參見第二圖,第二圖為各種菌株在含有阿拉伯糖之LB培養基好氧情況下(A)生長曲線及(B)糖含量。 Please refer to the first figure. The first figure shows the growth curves of various strains only under aerobic conditions in LB medium. As can be seen from the first figure, the OD 600 values of the strains were not significantly different within 10 hours from the beginning, and after 30 hours, the diploid Escherichia coli (JA, JB) showed a higher OD 600 value than the wild type. (WT) E. coli was 17.1% lower. In contrast, please refer to the second figure. The second figure shows the (A) growth curve and (B) sugar content of various strains in the aerobic condition of LB medium containing arabinose.

由第一圖與第二(A)圖相比較可發現,在一開始的10小時內各菌株之OD600值表現上差異不大,而在10~30小時之間,OD600值表現量明顯大幅增加(尤其是J2、J3、JA及JB菌株),更進一步地,時間拉長至30小時後,甚至到100小時,則可發現除J1之OD600值與W.T.類似之外,其餘菌株(J2、J3、JA及JB)之OD600值皆遠大於W.T.,由第二圖可明顯得知,J2、J3、JA及JB菌株發酵後之細胞乾重較W.T.增加200%-300%;由此可明顯推知,帶有經突變的核酮糖二磷酸羧化酶/加氧酶(rbcLS)之大腸桿菌菌株的OD600值表現量明顯較佳,表示將經突變的核酮糖二磷酸羧化酶/加氧酶(rbcLS)轉殖入大腸桿菌後可使其生長更有效率,並可明顯增加細胞乾重和碳源代謝。 Comparing the first figure with the second (A) figure, it can be found that the OD 600 value of each strain showed little difference in the first 10 hours, and the OD 600 value was obvious between 10 and 30 hours. Significantly increased (especially J2, J3, JA and JB strains), and further, after 30 hours, or even 100 hours, it can be found that the OD 600 value of J1 is similar to that of WT, and the other strains ( The OD 600 values of J2, J3, JA and JB) are much larger than WT. It can be clearly seen from the second figure that the dry weight of cells after fermentation of J2, J3, JA and JB strains is 200%-300% higher than that of WT; It can be clearly inferred that the OD 600 value of the E. coli strain with the mutated ribulose bisphosphate carboxylase/oxygenase (rbcLS) is significantly better, indicating that the ribulose bisphosphate is mutated. The enzyme/oxygenase (rbcLS) can be grown into E. coli to make it more efficient, and can significantly increase cell dry weight and carbon source metabolism.

同時,亦請參見第二(B)圖,一開始的阿拉伯糖含量為20g/L,在10小時內,各菌株的糖消耗量皆為差不多;然而,在10~30小時之間,糖消耗量明顯大幅增加(尤其是J2、J3、JA及JB菌株),經過30小時之後,甚至到100小時,則可發現則可發現除J1之糖消耗量與W.T類似之外,其餘菌株(J2、J3、JA及JB)之糖消耗量明顯大於W.T.;由此可明顯推知,帶有經突變的核酮糖二磷酸羧化酶/加氧酶(rbcLS)之大腸桿菌菌株可增加發酵速率,使得發酵效率增加且糖消耗量明顯變大。 At the same time, please also refer to the second (B) chart. The initial arabinose content is 20g/L. In 10 hours, the sugar consumption of each strain is similar; however, between 10 and 30 hours, sugar consumption Significantly increased the amount (especially J2, J3, JA and JB strains), after 30 hours, or even 100 hours, it can be found that the sugar consumption of J1 is similar to that of WT, and the other strains (J2) The sugar consumption of J3, JA and JB) is significantly greater than that of WT; it can be clearly inferred that the Escherichia coli strain with the mutated ribulose bisphosphate carboxylase/oxygenase (rbcLS) can increase the fermentation rate, The fermentation efficiency is increased and the sugar consumption is significantly increased.

請參見第三圖,第三圖為各株大腸桿菌發酵後所產生的二氧化碳 與乙酸、二氧化碳與乙醇的比例示意圖。如圖所示,於野生型大腸桿菌中二氧化碳與乙酸之比例遠較其他株高,這顯示野生株之二氧化碳不具備固定二氧化碳的能力,因此產生許多的二氧化碳。同時,二氧化碳與乙醇的比例於野生株中的比例亦較JB、J1及J2來的高。由此可知,經突變之酵素於大腸桿菌中的大量表現有助於固定二氧化碳,減少二氧化碳排放。 Please refer to the third figure. The third picture shows the carbon dioxide produced by fermentation of Escherichia coli. Schematic diagram of the ratio with acetic acid, carbon dioxide and ethanol. As shown, the ratio of carbon dioxide to acetic acid in wild-type E. coli is much higher than that of other plants, indicating that the carbon dioxide of wild-type plants does not have the ability to fix carbon dioxide, thus producing a lot of carbon dioxide. At the same time, the ratio of carbon dioxide to ethanol in wild plants is also higher than that of JB, J1 and J2. It can be seen that the large amount of mutant enzymes in E. coli helps to fix carbon dioxide and reduce carbon dioxide emissions.

第四圖為發酵槽各菌株中每單位糖消耗量之二氧化碳之柱狀比較圖。從此圖可以得知,無論是JB/pTA及JB/pTB或是JB/pTA+IPTG及JB/pTB+IPTG皆比E.coli BL21(DE3)及JB少,在糖消耗完畢時,所有菌株的葡萄糖皆已消耗殆盡,因此證明了在每單位的糖消耗,JB/pTA、JB/pTB、JB/pTA+IPTG及JB/pTB+IPTG確實比JB的二氧化碳排放降低許多,也證明了利用tktA基因、talB基因的表現,確實可以讓JB所排放的二氧化碳降低。 The fourth graph is a columnar comparison of carbon dioxide per unit sugar consumption in each strain of the fermentation tank. It can be seen from this figure that both JB/pTA and JB/pTB or JB/pTA+IPTG and JB/pTB+IPTG are less than E.coli BL21(DE3) and JB, and all strains are used when sugar consumption is completed. Glucose has been depleted, thus demonstrating that JB/pTA, JB/pTB, JB/pTA+IPTG and JB/pTB+IPTG are indeed much lower than JB's CO2 emissions per unit of sugar consumption, also demonstrating the use of tktA. The performance of the gene and talB gene can indeed reduce the carbon dioxide emitted by JB.

第五圖為發酵槽各菌株中每單位糖消耗量之乙醇及乙酸之產量之柱狀比較圖。由此圖可知,JB/pTA、JB/pTB、JB/pTA+IPTG及JB/pTB+IPTG比E.coli BL21(DE3)少,且等於或少於JB,因此說明JB和JB/pTA、JB/pTB、JB/pTA+IPTG及JB/pTB+IPTG相較於E.coli BL21(DE3)而言,可以有效地將排放的二氧化碳回到原本的系統中並加以利用,而且也讓一部分的碳再進一步產生乙醇或乙酸,達到了提高產物量之效果。 The fifth graph is a bar graph comparing the yield of ethanol and acetic acid per unit sugar consumption in each strain of the fermentation tank. As can be seen from the figure, JB/pTA, JB/pTB, JB/pTA+IPTG, and JB/pTB+IPTG are less than E.coli BL21(DE3), and are equal to or less than JB, thus indicating JB and JB/pTA, JB. Compared with E.coli BL21 (DE3), /pTB, JB/pTA+IPTG and JB/pTB+IPTG can effectively return the emitted carbon dioxide to the original system and use it, and also make a part of the carbon. Further production of ethanol or acetic acid achieves an effect of increasing the amount of the product.

第六圖為發酵槽各菌株中每單位乙醇及乙酸產量之二氧化碳排放量之柱狀比較圖。由二氧化碳排放量/乙醇+乙酸產量方面,JB/pTA及JB/pTB皆比E.coli BL21(DE3)及JB少6.25%及15.6%,因此可以說明,在每產生1莫耳的產物時,JB/pTA及JB/pTB、所 排放的二氧化碳比E.coli BL21(DE3)和JB少,也說明了JB/pTA及JB/pTB皆可循環利用自身所排放之二氧化碳,使整個系統的副產物(二氧化碳)降低。 The sixth graph is a bar graph comparing the CO2 emissions per unit of ethanol and acetic acid production in each strain of the fermentation tank. From the aspects of carbon dioxide emissions/ethanol + acetic acid production, JB/pTA and JB/pTB are 6.25% and 15.6% less than E.coli BL21(DE3) and JB, so it can be explained that every time 1 mole of product is produced, JB/pTA and JB/pTB, The emission of carbon dioxide is less than that of E.coli BL21 (DE3) and JB. It also shows that both JB/pTA and JB/pTB can recycle the carbon dioxide emitted by themselves, which reduces the by-product (carbon dioxide) of the whole system.

綜上所述,本發明之用於對受質發酵形成發酵產物之微生物,具備下述優點: In summary, the microorganism of the present invention for forming a fermentation product by fermentation is provided with the following advantages:

(1)含有經突變之酵素序列之微生物可增加發酵產物之生產效率,且固定二氧化碳,減少二氧化碳排放。 (1) Microorganisms containing a mutated enzyme sequence can increase the production efficiency of the fermentation product, and fix carbon dioxide to reduce carbon dioxide emissions.

(2)增加氫氣於氣相產物中之比例,可降低氫氣純化之成本。 (2) Increasing the proportion of hydrogen in the gas phase product can reduce the cost of hydrogen purification.

(3)無論於有氧或無氧環境中,重組蛋白酵素的大量表現可明顯增加細胞乾重和碳源代謝。 (3) A large number of recombinant protein enzymes can significantly increase cell dry weight and carbon source metabolism in an aerobic or anaerobic environment.

(4)本發明所構築之質體,皆有再利用二氧化碳之功能;換句話說,即可在二氧化碳排放量最少的情況下發酵產生最多的產物。 (4) The plastids constructed by the present invention all have the function of reusing carbon dioxide; in other words, the most products can be produced by fermentation with the least amount of carbon dioxide emissions.

其它實施態 Other implementation

所有揭露於本發明書之特徵係可使用任何方式結合。本說明書所揭露之特徵可使用相同、相等或相似目的的特徵取代。因此,除了特別陳述強調處之外,本說明書所揭露之特徵係為一系列相等或相似特徵中的一個實施例。 All features disclosed in this disclosure can be combined in any manner. Features disclosed in this specification can be replaced with features of the same, equivalent or similar purpose. Therefore, the features disclosed in this specification are one of a series of equivalent or similar features.

此外,依據本說明書揭露之內容,熟悉本技術領域者係可輕易依據本發明之基本特徵,在不脫離本發明之精神與範圍內,針對不同使用方法與情況作適當改變與修飾,因此,其它實施態樣亦包含於申請專利範圍中。 In addition, according to the disclosure of the present specification, those skilled in the art can easily make appropriate changes and modifications to different methods and situations without departing from the spirit and scope of the present invention. The implementation aspect is also included in the scope of the patent application.

Claims (9)

一種用於對受質發酵並固定二氧化碳之微生物,其包含含有經突變或非經突變之酵素序列之質體或染色體,該經突變或該非經突變之酵素係包含選自由以下序列結構之質體或染色體所構成之群組:pACYC184-PrkA/pET-rbcLSm1/tktA(JB/PTA)及pACYC184-PrkA/pET-rbcLSm1/talB(JB/pTB);其中,該受質為一六碳糖、一六碳糖衍生物或其組合;其中,具備該序列結構之質體或染色體之微生物發酵後每單位C2有機物消耗量之二氧化碳排放量較野生型菌株減少6.25%-15.6%。 A microorganism for fermenting and immobilizing carbon dioxide, comprising a plastid or chromosome comprising a mutated or non-mutated enzyme sequence, the mutated or non-mutated enzyme comprising a plastid selected from the following sequence structure Or a group consisting of: pACYC184-PrkA/pET-rbcLSm1/tktA (JB/PTA) and pACYC184-PrkA/pET-rbcLSm1/talB (JB/pTB); wherein the receptor is a six-carbon sugar, one A hexasaccharide derivative or a combination thereof; wherein the carbon dioxide emission per unit C2 organic matter consumption after fermentation of the plastid or chromosome having the sequence structure is reduced by 6.25%-15.6% compared with the wild type strain. 如申請專利範圍第1項所述之微生物,其中該微生物為真菌。 The microorganism of claim 1, wherein the microorganism is a fungus. 如申請專利範圍第2項所述之微生物,其中該真菌係為酵母菌屬。 The microorganism according to claim 2, wherein the fungus is a genus of yeast. 如申請專利範圍第1項所述之微生物,其中該微生物為細菌或古細菌(archaea)或其組合。 The microorganism of claim 1, wherein the microorganism is a bacterium or an archaea or a combination thereof. 如申請專利範圍第4項所述之微生物,其中該細菌係為大腸桿菌(Escherichia coli)、丙酮丁醇梭桿菌(Clostridium acetobutylicum)、枯草芽孢桿菌(Bacillus subtilis)、戀臭假單胞菌(Pseudomonas putia)、藍藻細菌(cyanobacteria)、貪銅菌屬(Cupriavidus spp.)或運動發酵單胞菌(Zymomonas mobilis)或其組合。 The microorganism according to claim 4, wherein the bacterium is Escherichia coli, Clostridium acetobutylicum, Bacillus subtilis, Pseudomonas Putia), cyanobacteria, Cupriavidus spp. or Zymomonas mobilis or a combination thereof. 如申請專利範圍第1項所述之微生物,其中該微生物為藻類。 The microorganism of claim 1, wherein the microorganism is an alga. 如申請專利範圍第1項所述之微生物,其中該六碳糖衍生物為該六碳糖聚合之雙糖、寡聚醣或多醣。 The microorganism according to claim 1, wherein the hexose sugar derivative is a hexasaccharide-polymerized disaccharide, oligosaccharide or polysaccharide. 如申請專利範圍第1項所述之微生物,其中該微生物係以一半厭氧的環境下進行發酵工程。 The microorganism according to claim 1, wherein the microorganism is subjected to fermentation engineering in a half anaerobic environment. 根據申請專利範圍第1項之微生物,其中該微生物係以一液態發酵槽進行發酵工程。 The microorganism according to claim 1, wherein the microorganism is subjected to a fermentation process in a liquid fermentation tank.
TW102147336A 2012-12-21 2013-12-20 Microrganism for forming fermentation products through fermentation of sugars TWI546379B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW102147336A TWI546379B (en) 2012-12-21 2013-12-20 Microrganism for forming fermentation products through fermentation of sugars

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW101149099 2012-12-21
TW102147336A TWI546379B (en) 2012-12-21 2013-12-20 Microrganism for forming fermentation products through fermentation of sugars

Publications (2)

Publication Number Publication Date
TW201425579A TW201425579A (en) 2014-07-01
TWI546379B true TWI546379B (en) 2016-08-21

Family

ID=51725261

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102147336A TWI546379B (en) 2012-12-21 2013-12-20 Microrganism for forming fermentation products through fermentation of sugars

Country Status (1)

Country Link
TW (1) TWI546379B (en)

Also Published As

Publication number Publication date
TW201425579A (en) 2014-07-01

Similar Documents

Publication Publication Date Title
Singh et al. Cellulosic ethanol production via consolidated bioprocessing by a novel thermophilic anaerobic bacterium isolated from a Himalayan hot spring
JP5723290B2 (en) Zymomonas with improved xylose utilization under stress conditions (ZYMOMONAS)
Kurosawa et al. Engineering xylose metabolism in triacylglycerol-producing Rhodococcus opacus for lignocellulosic fuel production
Ezeji et al. Fermentation of dried distillers’ grains and solubles (DDGS) hydrolysates to solvents and value-added products by solventogenic clostridia
Guo et al. Performances of Lactobacillus brevis for producing lactic acid from hydrolysate of lignocellulosics
Ginkel et al. Biohydrogen production as a function of pH and substrate concentration
Sinha et al. Biohydrogen production from various feedstocks by Bacillus firmus NMBL-03
Karagöz et al. Ethanol production from wheat straw by Saccharomyces cerevisiae and Scheffersomyces stipitis co-culture in batch and continuous system
DK2593540T3 (en) Microorganisms with extended substratudnyttelsesområde
Das et al. Enhanced bioethanol production from water hyacinth (Eichhornia crassipes) by statistical optimization of fermentation process parameters using Taguchi orthogonal array design
Xu et al. Factors influencing cellulosome activity in consolidated bioprocessing of cellulosic ethanol
Li et al. Bioethanol production from rice straw by a sequential use of Saccharomyces cerevisiae and Pichia stipitis with heat inactivation of Saccharomyces cerevisiae cells prior to xylose fermentation
US20090258404A1 (en) Production of fermentation products in biofilm reactors using microorganisms immobilised on sterilised granular sludge
Jamali et al. Particle size variations of activated carbon on biofilm formation in thermophilic biohydrogen production from palm oil mill effluent
WO2016191625A1 (en) Genetically engineered microorganisms for the production of chorismate-derived products
Wang et al. Optimal production of 4-deoxy-L-erythro-5-hexoseulose uronic acid from alginate for brown macro algae saccharification by combining endo-and exo-type alginate lyases
Yuan et al. Microalgae pretreatment with liquid hot water to enhance enzymatic hydrolysis efficiency
Al-Shorgani et al. Biohydrogen production from agroindustrial wastes via Clostridium saccharoperbutylacetonicum N1-4 (ATCC 13564)
Fu et al. High-selectivity butyric acid production from Saccharina japonica hydrolysate by Clostridium tyrobutyricum
Gupta et al. Bioethanol production from hemicellulose rich Populus nigra involving recombinant hemicellulases from Clostridium thermocellum
JP2024009798A (en) Production of polyhydroxybutyrate in wood-ljungdahl microorganism
Qu et al. Enhanced ethanol production from lignocellulosic hydrolysates by Thermoanaerobacterium aotearoense SCUT27/ΔargR1864 with improved lignocellulose-derived inhibitors tolerance
Qu et al. The redox-sensing transcriptional repressor Rex is important for regulating the products distribution in Thermoanaerobacterium aotearoense SCUT27
TWI516599B (en) A method of producing butyric acid
Chang et al. Conversion efficiency of bioethanol from levoglucosan was improved by the newly engineered Escherichia coli

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees